These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 28225457

  • 1. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 2. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Chen J, Li ZY, Zhang RG, Zhu F, Wu G.
    Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
    [Abstract] [Full Text] [Related]

  • 3. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Li ZY, Zhang RG, Zhu F, Wu G.
    Int J Cancer; 2019 May 01; 144(9):2227-2238. PubMed ID: 30374974
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T, Takahashi T, Shibuya T, Amita M, Henmi N, Takahashi K, Kurachi H.
    Cancer Biol Ther; 2012 Jan 01; 13(1):25-33. PubMed ID: 22336585
    [Abstract] [Full Text] [Related]

  • 5. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
    Zhang JG, Li XY, Wang YZ, Zhang QD, Gu SY, Wu X, Zhu GH, Li Q, Liu GL.
    PLoS One; 2014 Jan 01; 9(9):e107661. PubMed ID: 25238232
    [Abstract] [Full Text] [Related]

  • 6. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
    Chen W, Mao K, Hua-Huy T, Bei Y, Liu Z, Dinh-Xuan AT.
    Oncol Rep; 2014 Dec 01; 32(6):2795-802. PubMed ID: 25333508
    [Abstract] [Full Text] [Related]

  • 7. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY, Dun JN, Miao QF, Zhang YJ.
    Pharmacology; 2009 Dec 01; 83(2):67-79. PubMed ID: 19052484
    [Abstract] [Full Text] [Related]

  • 8. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
    Eisa-Beygi S, Wen XY.
    Antiviral Res; 2015 Feb 01; 114():53-6. PubMed ID: 25512227
    [Abstract] [Full Text] [Related]

  • 9. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
    Qi Y, Liang X, Dai F, Guan H, Sun J, Yao W.
    Int J Mol Sci; 2020 Jul 29; 21(15):. PubMed ID: 32751352
    [Abstract] [Full Text] [Related]

  • 10. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.
    Diabetes; 2009 Jan 29; 58(1):215-26. PubMed ID: 18840783
    [Abstract] [Full Text] [Related]

  • 11. Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
    Miyamoto C, Maehata Y, Ozawa S, Ikoma T, Kubota E, Izukuri K, Kato Y, Hata R, Lee MC.
    J Pharmacol Sci; 2012 Jan 29; 120(3):241-9. PubMed ID: 23099322
    [Abstract] [Full Text] [Related]

  • 12. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ, Chen H, Chen Y, Xu ZP, Zhu LL, Yu W, Han YF, Dai YT.
    Zhonghua Nan Ke Xue; 2016 Jun 29; 22(6):483-490. PubMed ID: 28963834
    [Abstract] [Full Text] [Related]

  • 13. Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.
    Zhang JG, Zhang DD, Wu X, Wang YZ, Gu SY, Zhu GH, Li XY, Li Q, Liu GL.
    BMC Cancer; 2015 Oct 28; 15():814. PubMed ID: 26510899
    [Abstract] [Full Text] [Related]

  • 14. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR.
    Diabetes; 2008 Mar 28; 57(3):714-23. PubMed ID: 18083785
    [Abstract] [Full Text] [Related]

  • 15. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z, Ren JH, Li ZY, Nong L, Wu G.
    Oncol Rep; 2012 May 28; 27(5):1561-6. PubMed ID: 22344855
    [Abstract] [Full Text] [Related]

  • 16. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L.
    Med Oncol; 2011 Jun 28; 28(2):565-71. PubMed ID: 20300976
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
    Sezen SF, Lagoda G, Musicki B, Burnett AL.
    J Sex Med; 2014 Sep 28; 11(9):2164-71. PubMed ID: 24919622
    [Abstract] [Full Text] [Related]

  • 18. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H, Shimizu K.
    Cancer Sci; 2011 Feb 28; 102(2):393-9. PubMed ID: 21166955
    [Abstract] [Full Text] [Related]

  • 19. Fasudil alleviates acetaminophen-induced liver injury via targeting Rhoa/ROCK signal pathway.
    Ren X, Meng T, Ren X, Li X, Lu L.
    J Toxicol Sci; 2021 Feb 28; 46(6):255-262. PubMed ID: 34078832
    [Abstract] [Full Text] [Related]

  • 20. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
    Rao J, Ye Z, Tang H, Wang C, Peng H, Lai W, Li Y, Huang W, Lou T.
    Sci Rep; 2017 Jan 05; 7():39727. PubMed ID: 28054559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.